ORAL CONTRACEPTIVES AND ACUTE INTERMITTENT PORPHYRIA.
D002741:Chlorotrianisene; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D004054:Diethylstilbestrol; D004967:Estrogens / Q000627:therapeutic use*; D004966:Estrogens, Conjugated (USP); D004997:Ethinyl Estradiol; D005260:Female; D006801:Humans; D008107:Liver Diseases; D008525:Medroxyprogesterone; D008660:Metabolism; D009640:Norethindrone; D009641:Norethynodrel; D017118:Porphyria, Acute Intermittent; D011164:Porphyrias; D014116:Toxicology
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D004967:Estrogens; D004966:Estrogens, Conjugated (USP); D004997:Ethinyl Estradiol; D002741:Chlorotrianisene; D004054:Diethylstilbestrol; D009641:Norethynodrel; D008525:Medroxyprogesterone; D009640:Norethindrone
CHLOROTRIANISENE; CONTRACEPTIVES, ORAL; DIETHYLSTILBESTROL; ESTROGENIC SUBSTANCES, CONJUGATED; ESTROGENS, THERAPEUTIC; ETHINYL ESTRADIOL; LIVER DISEASES; MEDROXYPROGESTERONE; METABOLISM; NORETHINDRONE; NORETHYNODREL; PORPHYRIA; TOXICOLOGIC REPORT